Literature DB >> 14529540

Runx2/Cbfa1: a multifunctional regulator of bone formation.

J B Lian1, G S Stein.   

Abstract

Runx2/Cbfa/AML3 is a member of the runt homology domain family of transcription factors, essential for osteoblast differentiation and bone formation. Defining the molecular mechanisms by which Runx2 can function as a master regulatory gene for activating the program of osteoblastogenesis has provided novel insights for transcriptional regulation of tissue-specific genes. Regulation of Runx expression has the potential to serve as a basis for the design of novel therapeutic strategies for promoting bone formation. Here we review the unique properties of Runx2 that mediate several key functions necessary for regulating skeletogenesis, controlling osteoblast growth and differentiation, and integrating the complex pathways required for bone formation and turnover.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14529540     DOI: 10.2174/1381612033453659

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  52 in total

1.  Sequence-specific DNA binding by the alphaNAC coactivator is required for potentiation of c-Jun-dependent transcription of the osteocalcin gene.

Authors:  Omar Akhouayri; Isabelle Quélo; René St-Arnaud
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 2.  Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs.

Authors:  Jan O Gordeladze; Farida Djouad; Jean-Marc Brondello; Daniele Noël; Isabelle Duroux-Richard; Florence Apparailly; Christian Jorgensen
Journal:  Acta Pharmacol Sin       Date:  2009-10       Impact factor: 6.150

3.  Effect of low-intensity pulsed ultrasound on the biological behaviors of bone marrow mesenchymal stem cells on titanium with different surface topographies.

Authors:  Yanxin An; Yan Song; Zhaoling Wang; Jing Wang; Gaoyi Wu; Guoxiong Zhu; Lei Chen
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

4.  Local supplementation with plant-derived recombinant human FGF2 protein enhances bone formation in critical-sized calvarial defects.

Authors:  Sher Bahadur Poudel; Chang-Ki Min; Jeong-Hoon Lee; Yun-Ji Shin; Tae-Ho Kwon; Young-Mi Jeon; Jeong-Chae Lee
Journal:  J Bone Miner Metab       Date:  2019-03-06       Impact factor: 2.626

5.  Hypoxia Pretreatment Promotes Chondrocyte Differentiation of Human Adipose-Derived Stem Cells via Vascular Endothelial Growth Factor.

Authors:  Ok Kyung Hwang; Young Woock Noh; Jin Tae Hong; Je-Wook Lee
Journal:  Tissue Eng Regen Med       Date:  2020-05-26       Impact factor: 4.169

6.  Oncogenic cooperation between PI3K/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells.

Authors:  Sandhya Pande; Gillian Browne; Srivatsan Padmanabhan; Sayyed K Zaidi; Jane B Lian; Andre J van Wijnen; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2013-08       Impact factor: 6.384

7.  SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

Authors:  Jing Nie; E Helene Sage
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

8.  Case report: multiple fractures in a patient with mutations of TWIST1 and TNSALP.

Authors:  Florian Barvencik; Matthias Gebauer; Thorsten Schinke; Michael Amling
Journal:  Clin Orthop Relat Res       Date:  2008-01-25       Impact factor: 4.176

9.  Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice.

Authors:  Meilin Wu; Jun Li; Kurt A Engleka; Bo Zhou; Min Min Lu; Joshua B Plotkin; Jonathan A Epstein
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

10.  Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation.

Authors:  Tilo Dehne; Camilla Karlsson; Jochen Ringe; Michael Sittinger; Anders Lindahl
Journal:  Arthritis Res Ther       Date:  2009-09-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.